‘I Thought I Had This Thing Beat’: A Story of Relapse and Recovery

January 17, 2018 | Jennifer Mattson

In the summer of 2015, Mollie Warner was living a happy, active life in Rancho Cucamonga, California, with her husband. She worked out regularly at the gym, lifted weights and was even taking a kickboxing class when she started feeling fatigued.

Continue Reading

City of Hope Researcher Receives Grant to Improve Cognitive Outcomes in Young Cancer Patients

July 7, 2017 | Samantha Bonar

Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects in childhood cancer survivors from bilingual and Spanish-speaking families.

The Search for the Elephant Gene

July 5, 2017 | Michael Easterling

The African bull elephant is the largest mammal on the planet, comprised of trillions of cells that should ostensibly be a breeding ground for cancer. But because of an evolutionary anomaly, elephants don’t get cancer, a fact that fascinates Markus Müschen, M.D., Ph.D.

Novel anti-leukemia drug proves safe in phase 1 trials

December 15, 2015 | Elise Lamar

Older patients with acute myelogenous leukemia may ultimately have a drug that, if not made just for them, at least better meets their needs.

Scientists explore new approach to acute myeloid leukemia

December 10, 2015 | Chase Doyle

Sometimes, just a few remaining cancer cells can mean the difference between remission and relapse. For patients with aggressive bone marrow disease such as acute myeloid leukemia (AML), this distinction can be deadly.

City of Hope researchers are determined to eliminate those remaining cancer cells and, in doing so, improve patient survival. First, however, they must understand how resistance works.

In “Detour,” leukemia patient chronicles her journey back to health

December 8, 2015 | City of Hope

“You’re not in remission.”

Jane Wirth felt as if a Mac truck had hit her broadside. Stunned, she sat in her oncologist’s office in Northern California as the reality sank in. Those four words were a blow to her soul, yet they marked a turning point in her cancer journey.

What I learned: 7 questions for leukemia patient Alex Tung

November 26, 2015 | Denise Heady

Alex Tung, an avid surfer and resident of Cerritos, California, will not only mark the New Year on the Rose Parade float, but will also celebrate his new “first birthday.”

What I learned: 8 questions for leukemia survivor Anya Shah

November 23, 2015 | Denise Heady

Five City of Hope patients who have journeyed through cancer will welcome 2016 atop City of Hope's Tournament of Roses Parade float on January 1. The float’s theme, "The Miracle of Science with Soul", adds a deeper dimension to the parade theme of "Find your Adventure."

In acute myeloid leukemia treatment, infighting just might be positive

July 18, 2014 | Darrin Joy

Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia , or AML. In a new treatment for acute myeloid leukemia, Elizabeth Budde is using modified white blood cells to attack their malignant cousins.

Meet our doctors: Ravi Bhatia on better survival for leukemia patients

May 3, 2014 | Kim Proescholdt

Editor's Update: Ravi Bhatia has since left City of Hope. He joined the University of Alabama at Birmingham in January 2015. City of Hope Every four minutes, someone is diagnosed with a blood cancer. More than 156,000 new cases in the U.